Long-term aspirin use linked to lower risk for gastrointestinal tract cancers

(The JAMA Network Journals) Regular low doses of aspirin for at least six years was associated with a modestly reduced overall risk for cancer, primarily due to a lower risk for gastrointestinal tract cancer, especially colorectal cancers, according to an article published online by JAMA Oncology.